Benjamin Edwards’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Benjamin Edwards's DGX Position: Q3 2026 in Review
Benjamin Edwards increased its Quest Diagnostics (DGX) stake by 6.9% in Q3 2026, buying an estimated $118K and bringing the position to 7,959 shares worth $1.86M. The position accounts for 0.02% of the portfolio, ranked #595.
Benjamin Edwards first reported a position in DGX in Q2 2022 and has held it in 16 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Benjamin Edwards held 7,959 shares of Quest Diagnostics worth $1.86M as of Q3 2026.
- Benjamin Edwards bought 512 Quest Diagnostics shares in Q3 2026, an estimated $118K.
- Quest Diagnostics made up 0.02% of Benjamin Edwards's portfolio in Q3 2026, its #595 holding.
- Benjamin Edwards first reported a position in Quest Diagnostics in Q2 2022 and has held it in 16 quarters since.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.